Traynor Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $348K | Buy |
960
+40
| +4% | +$13.7K | 0.02% | 234 |
|
|
2026
Q1 | $321K | Sell |
920
-15
| -2% | -$5.35K | 0.02% | 235 |
|
|
2025
Q4 | $306K | Sell |
935
-21
| -2% | -$6.66K | 0.02% | 249 |
|
|
2025
Q3 | $270K | Buy |
956
+62
| +7% | +$18K | 0.02% | 261 |
|
|
2025
Q2 | $260K | Buy |
894
+201
| +29% | +$56.9K | 0.02% | 201 |
|
|
2025
Q1 | $216K | Sell |
693
-168
| -20% | -$49.6K | 0.02% | 200 |
|
|
2024
Q4 | $224K | Buy |
861
+213
| +33% | +$63.2K | 0.02% | 226 |
|
|
2024
Q3 | $209K | Sell |
648
-26
| -4% | -$8.51K | 0.01% | 226 |
|
|
2024
Q2 | $210K | Sell |
674
-19,625
| -97% | -$5.77M | 0.02% | 214 |
|
|
2024
Q1 | $5.77M | Buy |
20,299
+1,358
| +7% | +$397K | 0.5% | 37 |
|
|
2023
Q4 | $5.46M | Buy |
18,941
+1,650
| +10% | +$450K | 0.56% | 35 |
|
|
2023
Q3 | $4.65M | Buy |
17,291
+1,044
| +6% | +$261K | 0.58% | 37 |
|
|
2023
Q2 | $3.61M | Sell |
16,247
-179
| -1% | -$41.5K | 0.44% | 42 |
|
|
2023
Q1 | $3.97M | Sell |
16,426
-159
| -1% | -$39K | 0.57% | 37 |
|
|
2022
Q4 | $4.36M | Sell |
16,585
-228
| -1% | -$61.1K | 0.61% | 36 |
|
|
2022
Q3 | $3.79M | Buy |
16,813
+97
| +0.6% | +$23.5K | 0.68% | 33 |
|
|
2022
Q2 | $4.07M | Sell |
16,716
-1,303
| -7% | -$319K | 0.71% | 35 |
|
|
2022
Q1 | $4.36M | Buy |
18,019
+22
| +0.1% | +$5.05K | 0.57% | 37 |
|
|
2021
Q4 | $4.05M | Sell |
17,997
-8
| -0% | -$1.69K | 0.48% | 49 |
|
|
2021
Q3 | $3.83M | Sell |
18,005
-127
| -0.7% | -$29.2K | 0.52% | 44 |
|
|
2021
Q2 | $4.51M | Buy |
18,132
+383
| +2% | +$94.2K | 0.63% | 39 |
|
|
2021
Q1 | $4.42M | Buy |
17,749
+612
| +4% | +$146K | 0.73% | 36 |
|
|
2020
Q4 | $3.94M | Sell |
17,137
-1,269
| -7% | -$293K | 0.7% | 36 |
|
|
2020
Q3 | $4.18M | Buy |
18,406
+624
| +4% | +$155K | 0.96% | 23 |
|
|
2020
Q2 | $4.19M | Buy |
17,782
+1,945
| +12% | +$444K | 1.01% | 20 |
|
|
2020
Q1 | $3.21M | Buy |
15,837
+831
| +6% | +$182K | 1.14% | 20 |
|
|
2019
Q4 | $3.62M | Buy |
15,006
+137
| +0.9% | +$30.2K | 0.97% | 25 |
|
|
2019
Q3 | $2.88M | Buy |
14,869
+1,237
| +9% | +$237K | 0.9% | 28 |
|
|
2019
Q2 | $2.54M | Sell |
13,632
-247
| -2% | -$44.2K | 0.83% | 27 |
|
|
2019
Q1 | $2.64M | Buy |
13,879
+1,234
| +10% | +$236K | 0.88% | 25 |
|
|
2018
Q4 | $2.46M | Buy |
12,645
+1,237
| +11% | +$241K | 1.03% | 24 |
|
|
2018
Q3 | $2.36M | Buy |
11,408
+855
| +8% | +$169K | 0.77% | 27 |
|
|
2018
Q2 | $1.95M | Buy |
10,553
+1,123
| +12% | +$199K | 0.71% | 30 |
|
|
2018
Q1 | $1.61M | Buy |
9,430
+1,157
| +14% | +$212K | 0.65% | 31 |
|
|
2017
Q4 | $1.44M | Buy |
8,273
+2,248
| +37% | +$398K | 0.61% | 35 |
|
|
2017
Q3 | $1.12M | Buy |
6,025
+350
| +6% | +$62K | 0.53% | 41 |
|
|
2017
Q2 | $977K | Buy |
5,675
+1,487
| +36% | +$242K | 0.48% | 45 |
|
|
2017
Q1 | $685K | Buy |
4,188
+1,011
| +32% | +$168K | 0.38% | 57 |
|
|
2016
Q4 | $490K | Sell |
3,177
-380
| -11% | -$57.2K | 0.32% | 66 |
|
|
2016
Q3 | $573K | Buy |
3,557
+114
| +3% | +$19.3K | 0.41% | 54 |
|
|
2016
Q2 | $531K | Buy |
3,443
+270
| +9% | +$42K | 0.42% | 54 |
|
|
2016
Q1 | $475K | Sell |
3,173
-87
| -3% | -$12.9K | 0.38% | 57 |
|
|
2015
Q4 | $529K | Sell |
3,260
-72
| -2% | -$11.3K | 0.38% | 60 |
|
|
2015
Q3 | $460K | Buy |
3,332
+649
| +24% | +$102K | 0.4% | 55 |
|
|
2015
Q2 | $412K | Buy |
2,683
+1,403
| +110% | +$225K | 0.34% | 64 |
|
|
2015
Q1 | $204K | Buy |
+1,280
| New | +$202K | 0.2% | 108 |
|
Other funds holding AMGN
FFM
SP
SMDAM
CRM
Traynor Capital Management's AMGN Position: Q2 2026 in Review
Traynor Capital Management increased its Amgen (AMGN) stake by 4.3% in Q2 2026, buying an estimated $13.7K and bringing the position to 960 shares worth $348K. The position accounts for 0.02% of the portfolio, ranked #234.
Traynor Capital Management first reported a position in AMGN in Q1 2015 and has held it in 46 quarters since. The position peaked at $5.77M in Q1 2024. 985 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Traynor Capital Management held 960 shares of Amgen worth $348K as of Q2 2026.
- Traynor Capital Management bought 40 Amgen shares in Q2 2026, an estimated $13.7K.
- Amgen made up 0.02% of Traynor Capital Management's portfolio in Q2 2026, its #234 holding.
- Traynor Capital Management first reported a position in Amgen in Q1 2015 and has held it in 46 quarters since.
- Traynor Capital Management's Amgen position peaked at $5.77M in Q1 2024.
- 985 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Traynor Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.